Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Heat Shock 27 kDa Protein-Related Disorders via the HSPB1 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Predominantly distal muscular atrophy Genologica Medica Spain | 43 | 18 |
|
Spinal muscular atrophy panel. 30-gene NGS panel. Genologica Medica Spain | 65 | 30 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center, Location AMC Netherlands | 2 | 1 |
|
Charcot-Marie-Tooth Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 85 | 30 |
|
Charcot-Marie-Tooth disease: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 67 | 54 |
|
Charcot-Marie-Tooth Hereditary Neuropathy NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 76 | 54 |
|
Spinal Muscular Atrophy NGS Panel Fulgent Genetics United States | 93 | 29 |
|
Paroxysmal Extreme Pain Disorder NGS Panel Fulgent Genetics United States | 185 | 53 |
|
Charcot-Marie-Tooth Disease Type 2 , Panel Massive Sequencing (NGS) 20 Genes Reference Laboratory Genetics Spain | 24 | 20 |
|
Charcot-Marie-Tooth Disease, Panel Massive Sequencing (NGS) 32 Genes Reference Laboratory Genetics Spain | 41 | 32 |
|
Hereditary Peripheral Neuropathy , Panel Massive Sequencing (NGS) 31 Genes Reference Laboratory Genetics Spain | 41 | 31 |
|
CHARCOT-MARIE-TOOTH DISEASE TYPE 2F Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Neuromuscular Disorders NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 233 | 144 |
|
Charcot-Marie-Tooth Disease Type 2F, Sequencing HSPB1Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
CMT Advanced Evaluation - Nonprevalent Axonal Athena Diagnostics Inc United States | 13 | 11 |
|
Atypical Spinal Muscular Atrophy Advanced Sequencing Evaluation Athena Diagnostics Inc United States | 10 | 10 |
|
CMT Advanced Evaluation - Nonprevalent Athena Diagnostics Inc United States | 25 | 21 |
|
Charcot-Marie-Tooth neuropathy type 2F Bioarray Spain | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.